Evidence map›Paper›PMID 34095295›Full record

ArticleBioMed research international2021

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).

Michele Miranda, Francesco Gianfreda, Carlo Raffone, Donato Antonacci, Valeria Pistilli, Patrizio Bollero

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Using platelet concentrates to treat maxillofacial tissue lesions.Frontiers in bioengineering and biotechnology · 2024
    Review
  13. Review
  14. Article
  15. Platelet-Rich Fibrin in Oral Surgery and Implantology: A Narrative Review.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  16. Article
  17. Growth Factor Release within Liquid and Solid PRF.Journal of clinical medicine · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michele MirandaDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID https://orcid.org/0000-0002-3069-3173
Francesco GianfredaDepartment of Industrial Engineering, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID https://orcid.org/0000-0001-5123-8666
Carlo RaffoneIndependent Researcher, 00198 Rome, Italy.
Donato AntonacciIndependent Researcher, 70121 Bari, Italy.ORCID https://orcid.org/0000-0002-8112-2741
Valeria PistilliIndependent Researcher, 00198 Rome, Italy.ORCID https://orcid.org/0000-0003-3805-1420
Patrizio BolleroDepartment of System Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID https://orcid.org/0000-0003-2430-2057
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dentoalveolar surgery is probably the major risk factor for MRONJ and for other complications following a tooth extraction, especially in patients affected by systemic diseases. The aim of this retrospective study is to evaluate whether a PRF plug inserted in the post extraction socket can prevent the onset of MRONJ. The patients were divided into two groups according to the surgical protocol that included the insertion or not of the PRF following the extraction and all the anamnestic, and clinical data were analyzed. In the control group, 5 patients developed MRONJ (19.23%) while in the study group, any case of MRONJ was reported. In the control group, patients who developed MRONJ had a CTX with less than 100 pg/mL (5 high-risk patients, Spearman's rank

Indexed as

AgedAged, 80 and overBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsFemaleHumansMaleMiddle AgedPlatelet-Rich FibrinRetrospective StudiesTooth ExtractionWound HealingBone Density Conservation Agents

Identifiers

PMID34095295
PMCPMC8140838
OpenAlexW3160487378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.